Company intelligence / Profile preview

Fuzhou Jinqiang Investment Partnership

Fuzhou, Fujian, China

Ownership: Private
Development stage: Other

Overview

Fuzhou Jinqiang Investment Partnership is an investment partnership based in China that is best known for its role as a founding partner in FF Gene Biotech, a joint venture focused on NGS-based genetic testing in fields such as oncology, reproductive health, and pediatrics in China.

Industry: Investors

Partnerships

FF Gene Biotech (Joint Venture: Fulgent Genetics, Xilong Scientific, Fuzhou Jinqiang Investment Partnership)

Beyond the preview

Go deeper on Fuzhou Jinqiang Investment Partnership.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fuzhou Jinqiang Investment Partnership.

Explore the full profile